Sem­ma goes on a suc­cess­ful ‘fish­ing’ ex­pe­di­tion in its hunt for a di­a­betes cure

Sem­ma Ther­a­peu­tics is re­port­ing some key progress in its com­plex pur­suit of a cure for Type 1 di­a­betes.

In a new study pub­lished in Na­ture, re­searchers at Har­vard and the biotech say they’ve made a ma­jor leap in their abil­i­ty to trans­form stem cells in­to a high con­cen­tra­tion of in­sulin-pro­duc­ing be­ta cells. Start­ing out at 30% pu­ri­ty, they’ve upped their av­er­age to 80%, open­ing the door wider to a brand new ther­a­peu­tic ap­proach.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.